Lifecore Biomedical, Inc. Securities Fraud Lawsuit Unveils Investor Opportunity Lifecore Biomedical, Inc. Securities Fraud Lawsuit Unveils Investor Opportunity

JJ Bounty

LOS ANGELES, Aug. 30, 2024 — Glancy Prongay & Murray LLP (“GPM”) announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Lifecore Biomedical, Inc. (“Lifecore” or the “Company”) LFCR.

Class Period: October 7, 2020 – March 19, 2024
Lead Plaintiff Deadline: September 27, 2024

If you wish to serve as lead plaintiff of the Lifecore lawsuit, you can submit your contact information at www.glancylaw.com/cases/Lifecore-Biomedical-Inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

The complaint filed alleges that, throughout the Class Period, Defendants failed to disclose to investors that Lifecore maintained deficient internal controls over financial reporting and issued inaccurate financial statements. This deception would require restatement. Furthermore, Lifecore’s supposed remediation efforts were ineffective, impairing their ability to meet SEC reporting and NASDAQ listing requirements. Consequently, the Company’s financial status was overstated, making Defendants’ statements misleading.

Follow us for updates on LinkedIn, Twitter, or Facebook.

To be a member of the class action, you need not take any action at this time; you may retain counsel of your choice or remain an absent member of the class action. For more information or questions, please contact Charles Linehan, Esquire, of GPM in Los Angeles, California.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts
Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com

See also  Next Week Could Be Huge for Super Micro Computer Stock. 2 Big Things Investors Need to Watch

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/lfcr-investors-have-opportunity-to-lead-lifecore-biomedical-inc-securities-fraud-lawsuit-302235368.html

SOURCE Glancy Prongay & Murray LLP

Market News and Data brought to you by Benzinga APIs